Nesteroidni antirevmatki (NSAR) so skupina zdravil, ki delujejo protibolečinsko, protivnetno in antipiretično. So varna in učinkovita zdravila, če jih uporabljamo v skladu z navodili. Kako in katera v katerih primerih? V primeru akutne bolečine je za pacienta najpomembnejše, da mu jo zdravilo čim hitreje olajša, zato je smiselno, da posežemo po zdravilu s hitrim sproščanjem. Če zdravimo kronično bolečino, je smiselno razmišljati v smeri čim manjše obremenitve s številom odmerkov v dnevu in predpis zdravila z dolgim delovanjem. <a href="https://public.mediately.co/assets/uporaba-nesteroidnih-antirevmatikov-v-klinicni-praksi.html" target="_blank" rel="noreferrer noopener">Preberite več</a>

<a href="https://public.mediately.co/assets/wp-uploads/2024/05/31083443/CME-SI-NSAR-Sara-Kenda.pdf" target="_blank" rel="noreferrer noopener">Vsebino izobraževanja si lahko ogledate v predstavitvi.</a>

<ol>
<li><a href="https://www.uptodate.com/contents/nonselective-nsaids-overview-of-adverse-effects" target="_blank" rel="noopener">UpToDate. Nonselective NSAIDs: Overview of adverse effects.</a> Citirano: 27.4.2024</li>
<li><a href="https://lek.si/sl/strokovna-javnost/strokovna-knjiznica/bolecina/varno-lajsanje-bolecine-z-analgetiki/" target="_blank" rel="noopener">Kenda S. Varno lajšanje bolečine z analgetiki.</a> Citirano: 27.4.2024</li>
<li><a href="https://www.mayoclinic.org/diseases-conditions/reyes-syndrome/symptoms-causes/syc-20377255" target="_blank" rel="noopener">Reye’s Syndrome &#8211; Symptoms and Causes. Mayo Clinic, 16 Feb. 2023.</a> Citirano: 27.4.2024</li>
<li><a href="https://lek.si/sl/strokovna-javnost/strokovna-knjiznica/bolecina/pravocasno-nad-bolecino/" target="_blank" rel="noopener">Kovačič A. Pravočasno nad bolečino</a>. Citirano: 28.4.2024</li>
<li>Fanelli, Andrea, et al. &#8220;Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications.&#8221; Therapeutic advances in drug safety 8.6 (2017): 173-182.</li>
<li>Dolinar, Tadeja, and Aleš Mrhar. &#8220;Paracetamol–učinkovito in varno zdravilo.&#8221; Farm Vestn 56 (2005): 229-240.</li>
<li>Bonnesen, Kasper, and Morten Schmidt. &#8220;Recategorization of non-aspirin nonsteroidal anti-inflammatory drugs according to clinical relevance: Abandoning the traditional NSAID terminology.&#8221; Canadian Journal of Cardiology 37.11 (2021): 1705-1707.</li>
<li><a href="http://www.cbz.si/cbz/bazazdr2.nsf/Search/$searchForm?SearchView" target="_blank" rel="noopener">Centralna baza zdravil.</a> Citirano: 28.4.2024, dosegljivo na:</li>
<li><a href="https://www.medicines.org.uk/emc/product/11547/smpc/print" target="_blank" rel="noopener">Ketorolac Trometamol 30 mg/mL Solution for Injection &#8211; Summary of Product Characteristics.</a> Citirano: 28.4.2024</li>
<li><a href="https://www.uptodate.com/contents/nsaids-including-aspirin-pharmacology-and-mechanism-of-action?search=acetylsalicylic%20acid&amp;source=search_result&amp;selectedTitle=3%7E150&amp;usage_type=default&amp;display_rank=3" target="_blank" rel="noopener">UpToDate. NSAIDs (including aspirin): pharmacology and mechanism of action.</a> Citirano 28.4.2024</li>
<li>Kötter, Thomas, et al. &#8220;Metamizole-associated adverse events: a systematic review and meta-analysis.&#8221; PloS one 10.4 (2015): e0122918.</li>
<li>Harirforoosh, Sam, and Fakhreddin Jamali. &#8220;Renal adverse effects of nonsteroidal anti-inflammatory drugs.&#8221; Expert opinion on drug safety 8.6 (2009): 669-681.</li>
<li><a href="http://www.davidlnelson.md/articles/TylenolNSAIDProtocol.html" target="_blank" rel="noopener">Managing arthritis pain without narcotics. David Lincoln Nelson, MD.</a> Citirano 28.4.2024</li>
<li>Malamatari, Maria. &#8220;The Importance of Drug Delivery in the Clinical Development and Lifecycle of Drug Products with Examples from Authorised Medicinal Products.&#8221; Processes 11.10 (2023): 2919.</li>
<li>Wolfe, M. Michael, David R. Lichtenstein, and Gurkirpal Singh. &#8220;Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.&#8221; New England Journal of Medicine 340.24 (1999): 1888-1899.</li>
<li>Štabuc, Borut, et al. &#8220;Smernice za preprečevanje in zdravljenje neželenih učinkov nesteroidnih protivnetnih in antiagregacijskih učinkovin na prebavila.&#8221; Slovenian Medical Journal 84.1 (2015).</li>
<li>Trelle, Sven, et al. &#8220;Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.&#8221; Bmj 342 (2011).</li>
<li>Graham, David J. &#8220;COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense.&#8221; Jama 296.13 (2006): 1653-1656.</li>
<li>Nissen, Steven E., et al. &#8220;Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis.&#8221; New England Journal of Medicine 375 (2016): 2519-2529.</li>
<li>Bhala, N., et al. &#8220;Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.&#8221; Lancet (London, England) 382.9894 (2013): 769-779.</li>
<li><a href="https://doctorabad.com/UpToDate/d/di.htm" target="_blank" rel="noopener">LexiComp Drug interaction checker. Citirano: 28.4.2024</a></li>
</ol>

Avtor/ji

Opravite izobraževanje in pridobite kreditne točke

Reference

Uporabite Mediately aplikacijo

Uporabite Mediately aplikacijo